Aprepitant
In StockAprepitant is a neurokinin-1 (NK1) receptor antagonist primarily used in combination regimens to prevent chemotherapy-induced nausea and vomiting (CINV). It targets the central pathways that trigger the vomiting reflex, offering long-lasting protection against both acute and delayed CINV. By effectively managing this difficult side effect, Aprepitant significantly improves the patient’s tolerance to chemotherapy treatments. It is a key component of highly effective supportive cancer care protocols.
What is Aprepitant?
Aprepitant is a prescription antiemetic medicine used to prevent nausea and vomiting caused by chemotherapy, surgery, or other medical treatments. It belongs to a class of drugs known as neurokinin-1 (NK1) receptor antagonists, which help block specific brain signals that trigger nausea. Aprepitant is available in capsule, tablet, and injectable forms, offering flexible treatment options for adults and adolescents undergoing cancer therapy or postoperative care.
Aprepitant Used For
Commonly, Aprepitant is prescribed to:
-
Prevent acute and delayed nausea and vomiting associated with cancer chemotherapy
-
Reduce the risk of postoperative nausea and vomiting (PONV) after surgery
-
Support combination therapy with other antiemetic drugs like ondansetron and dexamethasone
-
Improve quality of life for patients undergoing intensive medical treatments
This medication plays an important role in maintaining comfort and nutrition during recovery or cancer treatment.
Chemical Composition
Each Aprepitant capsule or tablet contains the active ingredient Aprepitant in various strengths such as 40 mg, 80 mg, or 125 mg. Inactive ingredients may include sucrose, gelatin, magnesium stearate, titanium dioxide, and microcrystalline cellulose, which help ensure stability and absorption.
Aprepitant Mechanism
Aprepitant works by blocking neurokinin-1 (NK1) receptors in the brain that interact with substance P, a chemical responsible for triggering nausea and vomiting. By preventing substance P from binding to NK1 receptors, Aprepitant reduces both the acute (immediate) and delayed (after 24 hours) phases of chemotherapy-induced nausea. This targeted mechanism makes it more effective when used with other antiemetics that block serotonin receptors.
How It Helps in Nausea and Vomiting Management
Aprepitant helps patients better tolerate chemotherapy or surgery by preventing the severe nausea that can interfere with treatment success. It provides comprehensive protection against vomiting during and after chemotherapy cycles. For patients recovering from surgery, it reduces the need for rescue medications and supports faster recovery and better hydration.
What Are Other Benefits
-
Enhances the effectiveness of other antiemetics when used in combination
-
Reduces the need for intravenous fluids caused by vomiting
-
Supports adherence to chemotherapy schedules
-
Suitable for both adults and adolescents above 12 years
-
Available in oral and intravenous formulations for convenience
Dosages
Available Strengths or Dosage
Aprepitant is available in 40 mg, 80 mg, and 125 mg strengths.
Typical regimens include:
-
Chemotherapy-induced nausea and vomiting (CINV):
-
Day 1: 125 mg taken 1 hour before chemotherapy
-
Days 2–3: 80 mg taken once daily in the morning
-
-
Postoperative nausea and vomiting (PONV):
-
Single 40 mg dose taken within 3 hours before anesthesia
-
Your doctor may adjust the dose based on your treatment plan and other medications.
How and When to Take It
-
Swallow Aprepitant tablets whole with a glass of water.
-
Can be taken with or without food.
-
For chemotherapy, begin the first dose before treatment starts.
-
Follow your prescribed schedule carefully to maintain consistent antiemetic coverage.
Overdose Caution
Taking excessive doses may lead to dizziness, headache, or gastrointestinal upset. In case of accidental overdose, seek immediate medical attention. Always store the medication out of reach of children and avoid sharing it with others.
Who Can Use/Take Aprepitant
Aprepitant is approved for adults and adolescents aged 12 years and older.
It may not be suitable for:
-
Pregnant or breastfeeding women unless specifically prescribed
-
Patients with severe liver impairment
-
Individuals allergic to Aprepitant or any of its components
-
Those taking medicines that strongly interact with CYP3A4 enzymes (such as pimozide or certain antivirals)
Your healthcare provider will assess your condition and adjust other medications to prevent drug interactions.
Side Effects & Precautions
What Are the Side Effects
Common side effects of Aprepitant include:
-
Fatigue or tiredness
-
Loss of appetite
-
Constipation or diarrhea
-
Headache or dizziness
-
Mild hiccups
Less common but serious side effects:
-
Allergic reactions like rash, swelling, or itching
-
Liver enzyme elevation or jaundice
-
Mood changes or anxiety
What Is the Precaution to Avoid Side Effects
-
Inform your doctor about all current medications, including herbal supplements.
-
Avoid alcohol consumption during treatment to reduce liver strain.
-
Monitor for signs of allergy after the first dose.
-
Use contraception during treatment and for 1 month after stopping, as Aprepitant may reduce the effectiveness of hormonal birth control.
-
Report any unusual tiredness, skin changes, or persistent nausea to your doctor promptly.
Always consult your oncologist or healthcare provider before starting treatment. If prescribed, you can order Aprepitant tablets online safely from trusted pharmacy sources and ensure timely refills to maintain your treatment progress.